[go: up one dir, main page]

MX2018005590A - Composiciones nutricionales para promover la funcion de barrera del intestino y mejorar el dolor visceral. - Google Patents

Composiciones nutricionales para promover la funcion de barrera del intestino y mejorar el dolor visceral.

Info

Publication number
MX2018005590A
MX2018005590A MX2018005590A MX2018005590A MX2018005590A MX 2018005590 A MX2018005590 A MX 2018005590A MX 2018005590 A MX2018005590 A MX 2018005590A MX 2018005590 A MX2018005590 A MX 2018005590A MX 2018005590 A MX2018005590 A MX 2018005590A
Authority
MX
Mexico
Prior art keywords
gut
barrier function
pediatric subject
gut barrier
lgg
Prior art date
Application number
MX2018005590A
Other languages
English (en)
Inventor
A F Van Tol Eric
Gross Gabriele
Tim Lambers Teartse
Waworuntu Rosaline
Manurung Sarmauli
Zhong Yan
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MX2018005590A publication Critical patent/MX2018005590A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente descripción está dirigida a métodos para i) promover la regeneración intestinal, ii) promover la maduración y/o adaptación del intestino, iii) apoyar la resistencia a la barrera del intestino y/o iv) proteger la función de la barrera del intestino en un sujeto pediátrico que comprende administrar al paciente pediátrico una composición que comprende una cantidad eficaz de una preparación de mediador soluble derivada de una fase de crecimiento exponencial tardío de un proceso de cultivo por lotes de probiótico, tal como Lactobacillus rhamnosus GG (LGG). Los presentes métodos proporcionan ventajosamente los beneficios de protección del intestino de mediadores solubles de LGG sin introducir cultivo bacteriano vivo en individuos con función de barrera intestinal deteriorada. En algunas modalidades, el sujeto pediátrico tiene una función de barrera del intestino deteriorada y/o síndrome de intestino corto. La presente descripción en otras modalidades, los métodos dirigidos para reducir el dolor visceral en un sujeto pediátrico que comprende administrar al sujeto pediátrico una composición que comprende una cantidad eficaz de una preparación mediadora soluble de una fase de crecimiento exponencial tardío de un proceso de cultivo por lotes de probiótico, tal como LGG.
MX2018005590A 2015-11-06 2016-10-10 Composiciones nutricionales para promover la funcion de barrera del intestino y mejorar el dolor visceral. MX2018005590A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/934,559 US9730969B2 (en) 2015-11-06 2015-11-06 Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
PCT/US2016/056207 WO2017078907A1 (en) 2015-11-06 2016-10-10 Nutritional compositions for promoting gut barrier function and ameliorating visceral pain

Publications (1)

Publication Number Publication Date
MX2018005590A true MX2018005590A (es) 2018-08-01

Family

ID=57200122

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018005590A MX2018005590A (es) 2015-11-06 2016-10-10 Composiciones nutricionales para promover la funcion de barrera del intestino y mejorar el dolor visceral.

Country Status (12)

Country Link
US (2) US9730969B2 (es)
EP (1) EP3370548A1 (es)
JP (1) JP2018537434A (es)
AR (1) AR106578A1 (es)
AU (1) AU2016348173A1 (es)
BR (1) BR112018008008A2 (es)
CA (1) CA3004062A1 (es)
MX (1) MX2018005590A (es)
PH (1) PH12018500969A1 (es)
SG (1) SG11201803127TA (es)
TW (1) TW201729824A (es)
WO (1) WO2017078907A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202657A1 (en) * 2017-05-05 2018-11-08 Nestec S.A. Treatment of infant colic
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US20190208807A1 (en) * 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
AU2021301341B2 (en) * 2020-06-30 2025-10-02 Allersinn Pty Ltd Allergen desensitisation
CN112568438B (zh) * 2020-12-07 2022-07-05 浙江华康药业股份有限公司 预防缓解肠道糖醇不耐受的甜味液及其制备方法和应用
CN115181683B (zh) * 2022-02-10 2023-10-03 江南大学 一株高富集有机锌的短双歧杆菌

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
SG49307A1 (en) 1991-01-24 1998-05-18 Martek Corp Microbial oil mixtures and use thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09509165A (ja) 1994-02-16 1997-09-16 ファーミング ベスローテン フェンノートシャップ ミルクからのラクトフェリンの分離
SE9503926D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
MXPA99007378A (es) 1997-02-11 2005-04-19 Entpr Ireland Cepas probioticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de lasmismas.
US6620326B1 (en) 1998-06-18 2003-09-16 Upfront Chromatography A/S Expanded bed adsorption system
US6682744B1 (en) * 1999-08-09 2004-01-27 University Of Maryland Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
NZ523049A (en) 2000-05-12 2005-09-30 Upfront Chromatography As A bed absorption system
AU2001256610A1 (en) 2000-05-12 2001-11-20 Alimentary Health Limited A probiotic adhesin product, derived from lactobacillus
NZ523995A (en) 2000-08-08 2005-03-24 Genesis Res & Dev Corp Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
DK1401289T3 (da) 2001-06-01 2005-07-18 Upfront Chromatography As Fraktionering af proteinholdige blandinger
DK1480524T3 (da) 2002-03-07 2013-07-15 Upfront Chromatography As Fremgangsmåde til isolering af lactoferrin
JP4712289B2 (ja) 2003-08-26 2011-06-29 株式会社エイ・エル・エイ 免疫促進用組成物
WO2005034971A2 (en) 2003-10-08 2005-04-21 Masami Moriyama Antiviral agent
CN1663573B (zh) 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
AU2006230772A1 (en) 2004-04-20 2006-11-16 The University Of Chicago Probiotic compounds from lactobacillus GG and uses therefor
CN1997748A (zh) 2004-04-20 2007-07-11 芝加哥大学 来自乳杆菌gg的益生化合物及其用途
FR2875406B1 (fr) 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
EP2032148A2 (en) 2006-05-12 2009-03-11 Danisco A/S, Danisco Intellectual Capital Composition containing lactobacillus sp. and a cannabinoid receptor and/or a opioid receptor agonist
JP5046684B2 (ja) 2007-02-28 2012-10-10 株式会社明治 腸管バリア機能の機能回復剤及び腸管バリア透過性の亢進阻害剤
FR2917623B1 (fr) 2007-06-22 2009-10-09 Lyoct Sa Lab Utilisation d'un probiotique pour la prevention des infections des voies respiratoires
RU2490324C2 (ru) 2007-12-26 2013-08-20 Лезаффр Э Компани ДРОЖЖИ Saccharomyces cerevisiae, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ПРОБИОТИКА, И КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
EE05341B1 (et) 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
US8431528B2 (en) 2008-05-16 2013-04-30 University Of Maryland, Baltimore Antibacterial Lactobacillus GG peptides and methods of use
JP5526320B2 (ja) 2008-09-04 2014-06-18 国立大学法人旭川医科大学 腸管保護剤
EP2295535A1 (en) 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
KR20110124516A (ko) 2010-05-11 2011-11-17 포항공과대학교 산학협력단 유산균 배양액 추출물을 포함하는 염증관련질환 치료용 조성물
WO2011148219A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US20150290261A1 (en) 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150290260A1 (en) 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305384A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20150305385A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
CN104509864B (zh) 2015-01-20 2016-09-07 北京东方兴企食品工业技术有限公司 一种具有改善胃肠功能的营养保健食品及其制备方法

Also Published As

Publication number Publication date
WO2017078907A1 (en) 2017-05-11
US20170128500A1 (en) 2017-05-11
US9730969B2 (en) 2017-08-15
AR106578A1 (es) 2018-01-31
BR112018008008A2 (pt) 2018-10-30
AU2016348173A1 (en) 2018-05-10
CA3004062A1 (en) 2017-05-11
EP3370548A1 (en) 2018-09-12
JP2018537434A (ja) 2018-12-20
US20170360855A1 (en) 2017-12-21
PH12018500969A1 (en) 2018-12-17
TW201729824A (zh) 2017-09-01
SG11201803127TA (en) 2018-05-30

Similar Documents

Publication Publication Date Title
PH12018500969A1 (en) Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
PH12015500633A1 (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
NZ764680A (en) Spray-dried 3-fucosyllactose
PH12015500634B1 (en) Method for preparing natural neutral flavor
RU2010146956A (ru) Новый штамм lactobacillus paracasei subspecies paracasei, обладающий антимикробными и иммуномодулирующими свойствами
SI3209310T1 (en) Compositions containing bacterial strains
PH12015500631A1 (en) Method for preparing natural beef flavor
PH12015500628B1 (en) Method for preparing natural kokumi flavor
RU2020132171A (ru) Новая бифидобактерия, характеризующаяся различными функциями, и ее применение
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
PH12013501877A1 (en) Nutritional compositions including branched chain fatty acids and methods of using same
MX348210B (es) Lactobacillus rhamnosus mejorador de sabor.
RU2010147343A (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
NZ627915A (en) Probiotic derived non-viable material for infection prevention and treatment
NZ631537A (en) Compositions and methods for modulating apolipoprotein c-iii expression
NZ598751A (en) Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175))
RU2014102762A (ru) Новая молочнокислая бактерия и способ производства с ее помощью силоса или ферментированного корма
MX2018002307A (es) Bacteria lactobacillus fermentum que reduce la concentracion de acetaldehido.
EA201490032A1 (ru) Лиофилизированные препараты fgf-18
CA3163217C (en) SUCROSE-NEGATIVE STREPTOCOCCUS THERMOPHILUS INTENDED FOR USE IN THE PREPARATION OF FERMENTED PRODUCTS
WO2014127351A3 (en) Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria
WO2015006287A3 (en) Compositions prepared from poultry and methods of their use
MX2019014315A (es) Bacterias probioticas preacondicionadas en un medio que contiene gos y uso de estas.
RU2007146645A (ru) Препарат бактериальный для производства ферментированных мясных изделий и биотрансформации мясного сырья